Skeletal Effects of a Prolonged Oral Metformin Treatment in Adult Wistar Rats
Experimental and Clinical Endocrinology & Diabetes · 01.10.2024 · 132 (10) · 547-556
DOI: 10.1055/a-2324-8661 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.10.2024. Verfasst von Nahuel E Wanionok und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Investigaciones en Osteopatías y Metabolismo Mineral (LIOMM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Argentin…. Hauptthemen laut MEDLINE: Metformin, Rats, Wistar, Osteogenesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: ANPCyT, Department of Physiological Sciences, University of Florida, Universidad Nacional de La Plata.
Abstract (Originalsprache)
Introduction
We previously showed that a 3-week oral metformin (MET) treatment enhances the osteogenic potential of bone marrow stromal cells (BMSCs) and improves several bone histomorphometric parameters in Wistar rats with metabolic syndrome (MetS). However, the skeletal effects of extended periods of MET need to be completely elucidated. Hence, in this study, the impact of a prolonged (3-month) MET treatment was investigated on bone architecture, histomorphometric and biomechanics variables, and osteogenic potential of BMSCs in Wistar rats with or without MetS. Materials and Methods Young male Wistar rats (n=36) were randomized into four groups (n=9) that received either 20% fructose (F), MET (MET), F plus MET treatments (FMET), or drinking water alone (Veh). Rats were euthanized, blood was collected, and bones were dissected and processed for peripheral quantitative computed tomography (pQCT) analysis, static and dynamic histomorphometry, and bone biomechanics. In addition, BMSCs were isolated to determine their osteogenic potential.
Results
MET affected trabecular and cortical bone, altering bone architecture and biomechanics. Furthermore, MET increased the pro-resorptive profile of BMSCs. In addition, fructose-induced MetS practically did not affect the the structural or mechanical variables of the skeleton.
Conclusion
A 3-month treatment with MET (with or without MetS) affects bone architecture and biomechanical variables in Wistar rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratorio de Investigaciones en Osteopatías y Metabolismo Mineral (LIOMM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Argentina.
- Department of Physiological Sciences, University of Florida, Gainesville, Florida, USA.
Förderung
- ANPCyT
- Department of Physiological Sciences, University of Florida
- Universidad Nacional de La Plata
Zitieren
APA
Wanionok, N. E., Molinuevo, M. S., Fernández, J. M., Lucas, B., Cortizo, A. M., Castillo, E. J., Jiron, J. M., Claudia, S., Leon, S., Aguirre, J. I., & McCarthy, A. D. (2024). Skeletal Effects of a Prolonged Oral Metformin Treatment in Adult Wistar Rats. Experimental and Clinical Endocrinology & Diabetes, 132(10), 547-556. https://doi.org/10.1055/a-2324-8661
Vancouver
Wanionok NE, Molinuevo MS, Fernández JM, Lucas B, Cortizo AM, Castillo EJ, et al. Skeletal Effects of a Prolonged Oral Metformin Treatment in Adult Wistar Rats. Experimental and Clinical Endocrinology & Diabetes. 2024;132(10):547-556. doi:10.1055/a-2324-8661
BibTeX
@article{Wanionok2024,
author = {Wanionok, Nahuel E and Molinuevo, María S and Fernández, Juan M and Lucas, Besada and Cortizo, Ana M and Castillo, Evelyn J and Jiron, Jessica M and Claudia, Sedlinsky and Leon, Schurman and Aguirre, José I and McCarthy, Antonio D},
title = {Skeletal Effects of a Prolonged Oral Metformin Treatment in Adult Wistar Rats},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2024},
volume = {132},
number = {10},
pages = {547--556},
doi = {10.1055/a-2324-8661}
}
EUVIMED